| |
| |
|
| Insider
Information: |
Dougherty Michael R |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
1,053,128 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$150,169 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,053,128 |
|
|
| Total
Value |
$150,169 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -40.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adolor Corp |
ADLR |
President & CEO |
2011-08-09 |
665,661 |
2004-06-16 |
0 |
Premium* |
|
|
Viropharma Inc |
VPHM |
Director |
2014-01-24 |
0 |
2008-11-03 |
0 |
Premium* |
|
|
Trevena Inc |
TRVN |
Director |
2014-12-10 |
7,000 |
2014-12-10 |
0 |
Premium* |
|
|
Melinta Therapeutics, Inc |
MLNT |
Director |
2015-10-26 |
2,000 |
2015-10-26 |
0 |
Premium* |
|
|
Foundation Medicine, Inc. |
FMI |
Director |
2018-07-31 |
0 |
2016-10-26 |
0 |
Premium* |
|
|
Marinus Pharmaceuticals Inc |
MRNS |
Director |
2022-02-04 |
3,312 |
|
0 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
|
2023-01-11 |
375,155 |
2019-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACGN |
Aceragen, Inc |
|
– • – |
2023-01-11 |
4 |
A |
$0.44 |
$14,750 |
D/D |
33,523 |
375,155 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
|
– • – |
2022-10-03 |
4 |
A |
$0.37 |
$21,938 |
D/D |
58,516 |
341,632 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
|
– • – |
2022-07-01 |
4 |
A |
$0.44 |
$21,938 |
D/D |
50,086 |
283,116 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
|
– • – |
2022-04-01 |
4 |
A |
$0.54 |
$22,018 |
D/D |
41,155 |
233,030 |
0 |
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
Director |
– • – |
2022-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
3,312 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
|
– • – |
2022-01-03 |
4 |
A |
$0.59 |
$21,867 |
D/D |
37,062 |
191,875 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2021-10-04 |
4 |
A |
$1.03 |
$21,866 |
D/D |
21,229 |
154,813 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
|
– • – |
2021-06-01 |
4 |
B |
$1.19 |
$101,150 |
D/D |
85,000 |
133,584 |
0.01 |
% |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2021-01-04 |
4 |
A |
$4.02 |
$14,130 |
D/D |
3,515 |
37,645 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-10-01 |
4 |
A |
$2.25 |
$12,875 |
D/D |
5,722 |
34,130 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-07-01 |
4 |
A |
$1.79 |
$12,875 |
D/D |
7,193 |
28,408 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-04-01 |
4 |
A |
$1.28 |
$12,876 |
D/D |
10,059 |
21,215 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-01-02 |
4 |
A |
$1.85 |
$13,018 |
D/D |
7,037 |
11,156 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2019-10-01 |
4 |
A |
$2.67 |
$10,998 |
D/D |
4,119 |
4,119 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2018-07-31 |
4 |
D |
$137.00 |
$1,735,653 |
D/D |
(12,669) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2018-07-31 |
4 |
D |
$137.00 |
$1,660,440 |
D/D |
(12,120) |
12,669 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2017-06-20 |
4 |
A |
$40.05 |
$231,729 |
D/D |
5,786 |
24,789 |
0 |
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
Director |
– • – |
2017-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,000 |
|
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2016-10-26 |
4 |
A |
$23.55 |
$447,521 |
D/D |
19,003 |
19,003 |
0 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
Director |
– • – |
2015-10-26 |
4 |
B |
$18.45 |
$36,896 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| TRVN |
Trevena Inc |
Director |
– • – |
2014-12-10 |
4 |
B |
$4.00 |
$28,000 |
D/D |
7,000 |
7,000 |
2.39 |
- |
|
| VPHM |
Viropharma Inc |
Director |
• • – |
2014-01-24 |
4 |
D |
$50.00 |
$1,040,600 |
D/D |
(20,812) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Director |
• • – |
2013-12-18 |
4 |
D |
$49.74 |
$34,221 |
D/D |
(688) |
20,812 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Director |
• • – |
2013-12-18 |
4 |
OE |
$3.42 |
$34,200 |
D/D |
10,000 |
21,500 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Director |
• • – |
2013-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
11,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
